Cytokeratins and other sensitive markers for esophageal cancer and metastases

Diseases of the Esophagus

Volumn 14, Issue 2, 2001, Pages 85-90

  Scheuemann, P ^a   Hosch, S B ^a   Izbicki, J R ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; MESSENGER RNA; NUCLEIC ACID; SQUAMOUS CELL CARCINOMA ANTIGEN;

ASSAY; BONE MARROW; CANCER SCREENING; CONFERENCE PAPER; DISEASE MARKER; ESOPHAGUS CANCER; ESOPHAGUS METASTASIS; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; ESOPHAGEAL NEOPLASMS; HUMANS; KERATINS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0034784482     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2001.00161.x     Document Type: Conference Paper

References (55)

1. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy
2. Plattenepithelcarzinom des ösophagus: Behandlungskonzept der Chirurgischen Klinik der Technischen Universität München
3. Plattenepithelcarcinom des oesophagus
4. Epidemiology of esophageal cancer from the European point of view
5. Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial
6. Immunocytochemical detection of disseminated tumor cells in bone marrow of patients with esophageal carcinoma
7. Early lymphatic tumor cell dissemination in pancreatic cancer: Frequency and prognostic significance
8. Malignant potential and prognostic impact of occult disseminated tumor cells in patients with esophageal cancer
9. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer
10. Minimal residual epithelial cancer: Diagnostic approaches and prognostic relevance
11. Micrometastasis in colorectal carcinoma: A review
12. Nucleic acid-based methods for detection of cancer
13. Micrometastases and survival in stage II colorectal cancer
14. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
15. Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer
16. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
17. Detection of hematogenous micrometastasis in patients with prostate cancer
18. Detection of hematogenous micrometastasis in patients with transitorial cell carcinoma
19. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19
20. Improved tumor staging in colorectal cancer
21. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer
22. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49
23. Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance
24. Cryptic tumor cells in lymph nodes of patients with esophageal cancer
25. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood
26. Limitations of reverse transcriptase-polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
27. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
28. Detection and clinical importance of micrometastatic disease
29. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
30. Epithelial cells in bone marrow of oesophageal cancer patients: A significant prognostic factor by multivariate analysis
31. Micrometastases in bone marrow of patients undergoing 'curative' surgery for gastrointestinal cancer
32. Early oesophageal cancer: Results of a European multicentre survey
33. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma
34. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies
35. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics, and impact on survival
36. Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma
37. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes
38. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
39. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction
40. Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance
41. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood
42. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
43. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction
44. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction
45. Detection of micrometastases in histopathologically negative lymph nodes in esophageal cancer
46. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques
47. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
48. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma
49. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA
50. Lymph node metastasis in resectable esophageal cancer
51. Standardisation of the immunocytochemical detection of cancer cells in bone marrow and blood: I. Establishment of objective criteria for the evaluation of immunostained cells
52. Classification of isolated tumor cells and micrometastasis
53. Identification of expressed genes by laser-mediated manipulation of single cells
54. Multiple mutation analyses in single tumor cells with improved whole genome amplification
55. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells